TokenPost·
BioNTech Agrees to Buy Scholar Rock’s FDA Voucher for $205 Million
BioNTech plans to use the voucher for a future filing involving an asset in its late-stage oncology pipeline.
More news
- TokenPostSparxity's Series A Financing Lifts Total Funding to $90 Million
- TokenPostRothschild & Co. Redburn Upgrades American Airlines to Buy
- TokenPostHecla Mining Sets Dec. 11 Redemption for Series B Preferred Stock
- crypto.newsStrategy’s MSCI exclusion could trigger billions in MSTR selling
- Crypto BriefingTether’s BotPsy AI model outperforms larger models in benchmarks
- TokenPostU.S. Stock Futures Diverge as Traders Await Inflation Report